BRIEF

on MEDIQON Group AG (isin : DE0006618309)

CHAPTERS Group AG Celebrates Successful 2023, Set to Continue Growth in 2024

CHAPTERS Group AG, in its recent communication, revealed the completion of a successful financial year in 2023 and is poised to maintain its positive momentum into 2024. Last year marked a significant transformation for the group, notably by incorporating 18 new operating companies and launching mlog, a VMS platform targeting the French market. The company strengthened its position in Fintiba by increasing its ownership. Moreover, its accomplishment included two fruitful funding rounds backed by major shareholders and new world-class investors.

The initial months of 2024 have seen the acquisition of three additional operating companies, expanding CHAPTERS Group AG's presence as a notable shareholder in Software Circle, a UK-based entity. Strategic team enhancements have been prioritized to support further growth, including key roles in operations and finance. CEO Jan-Hendrik Mohr expressed satisfaction with the group's progress and its strategic acquisitions, contributing to a 49% increase in EBITDA in 2023, which rose to approximately 63% with the 2024 transactions. The group's inorganic and organic growth strategies have significantly bolstered its financial performance.

Preliminary figures for 2023 indicate substantial revenue growth and an increased equity base, laying a solid foundation for further expansion. Adjusted EBITDA for 2023 of all majority-owned operating companies is estimated at around Euro 25m, marking a 49% increase from the previous year. In addition, the company foresees its consolidated and separate financial statements to be published in May 2023, following the completion of an audit and approval process. This forward momentum positions CHAPTERS Group AG for continued success in the dynamic European market.

R. E.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all MEDIQON Group AG news